Clinical Trials Directory

Trials / Sponsors / Regor Pharmaceuticals Inc.

Regor Pharmaceuticals Inc.

Industry · 7 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingStudy of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Breast Cancer, Ovarian Cancer, Endometrial Cancer
Phase 12026-04-01
Active Not RecruitingStudy of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight
Obesity or Overweight
Phase 22025-01-24
CompletedA Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity
Phase 22024-03-08
Active Not RecruitingA Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid
Breast Cancer, Advanced Solid Tumor
Phase 12023-04-17
TerminatedA Phase I Study of RGT-264 in Subjects With Advanced Solid Tumors
Advanced Solid Tumor
Phase 12023-02-15
TerminatedA Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes
Type 2 Diabetes Mellitus
Phase 22022-03-29
RecruitingFIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breas
Breast Cancer
Phase 12022-03-04